We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Adult Bone Marrow Stem Cells Can Differentiate Into Brain Cells

By Biotechdaily staff writers
Posted on 21 May 2003
A recent study has found that multipotent adult progenitor cells from adult bone marrow differentiate into all major types of brain cells after injection into mouse blastocysts.

Mice embryos treated in this fashion matured into chimeras expressing the presence of both the cells from the host mouse as well as cells that developed from the transplanted stem cells. More...
The transplanted cells were found to have differentiated into nerve cells, glial cells and myelin-forming cells. The study was published in the April 25, 2003, issue of Cell Transplantation.

The researchers looked at the specific phenotypes of the cells in the brain and found stem cells produced nerve cells in regions of the brain that undergo degeneration with Parkinson's disease, multiple sclerosis, Huntington's disease, Ataxia, and Alzheimer's disease. This finding increases the probability that stem cells could be used as therapy for these diseases.

"This tells us that these adult stem cells are capable of becoming nerve cells that communicate with other nerve cells within the brain and form proper neural circuits that permit the chimerical mice to function normally,” said contributing author Dr. Catherine Verfaillie, director of the Stem Cell Institute at the University of Minnesota (Minneapolis-St. Paul, USA).



Related Links:
University of Minnesota

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.